According to the LEfSe differences between KO groups, we further colored the pathway map, marked the detected genes and the gene biomarkers of each group, and found that the acpP gene was significantly expressed in the samples of type III prostatitis (Figure 6A). The gene discussed is ACP3; the disease is urogenital neoplasm.